Important MADIT-CRT Data Information

• This webinar is to be viewed in its entirety. Chapters are provided for ease of navigation.
• The following results presented by Dr. Moss reflect the full MADIT-CRT population for events occurring on or before June 22, 2009. The data used to support Boston Scientific's LBBB indication reflect an additional 6 months of data for events occurring on or before Dec 31, 2009.


• Subgroup analyses and substudies are exploratory and the results are considered suggestive and not definitive. Future studies would be needed to confirm these conclusions.


• Boston Scientific's CRT-D indication from the MADIT-CRT study is limited to the LBBB sub-population of that study.


• Boston Scientific does not intend to promote the use of its products for any other use than those approved by the FDA.